Henry Schein/$HSIC
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Henry Schein
Henry Schein Inc is a solutions company for healthcare professionals powered by a network of people and technology. The company is a provider of healthcare products and services to office-based dental and medical practitioners, as well as alternate sites of care. The company's reportable segments are Global Distribution and Value-Added Services; Global Specialty Products; and Global Technology. It generates the majority of its revenue from the Global Distribution and Value-Added Services segment, which includes distribution to the dental and medical markets of national brand and corporate brand merchandise, as well as equipment and related technical services.
Ticker
$HSIC
Sector
Primary listing
Industry
Health Care Providers and Services
Headquarters
Employees
25,000
Website
Henry Schein Metrics
BasicAdvanced
$8.8B
22.63
$3.21
0.87
-
Price and volume
Market cap
$8.8B
Beta
0.87
52-week high
$82.49
52-week low
$60.56
Average daily volume
1.7M
Financial strength
Current ratio
1.384
Quick ratio
0.585
Long term debt to equity
47.129
Total debt to equity
68.32
Interest coverage (TTM)
5.60%
Profitability
EBITDA (TTM)
1,029
Gross margin (TTM)
31.60%
Net profit margin (TTM)
3.21%
Operating margin (TTM)
6.06%
Effective tax rate (TTM)
24.08%
Revenue per employee (TTM)
$510,000
Management effectiveness
Return on assets (TTM)
4.61%
Return on equity (TTM)
8.47%
Valuation
Price to earnings (TTM)
22.627
Price to revenue (TTM)
0.72
Price to book
2.68
Price to tangible book (TTM)
-5.3
Price to free cash flow (TTM)
17.948
Free cash flow yield (TTM)
5.57%
Free cash flow per share (TTM)
404.61%
Growth
Revenue change (TTM)
1.75%
Earnings per share change (TTM)
8.11%
3-year revenue growth (CAGR)
0.04%
10-year revenue growth (CAGR)
1.99%
3-year earnings per share growth (CAGR)
-11.22%
10-year earnings per share growth (CAGR)
1.59%
What the Analysts think about Henry Schein
Analyst ratings (Buy, Hold, Sell) for Henry Schein stock.
Bulls say / Bears say
KKR's strategic investment of $250 million in Henry Schein, along with the addition of experienced directors, is expected to drive operational improvements and enhance shareholder value. (Henry Schein Press Release)
Henry Schein's recent acquisitions, including Shield Healthcare and TriMed, expand its product offerings and market reach, positioning the company for future growth. (Nasdaq)
The company's commitment to sustainability, validated by the Science Based Targets initiative, may attract ESG-focused investors and enhance its market reputation. (StockTitan)
Analysts have expressed concerns over Henry Schein's core growth rate, with projections indicating only 2-6% growth, excluding factors like cybersecurity normalization and acquisitions. (Markets Insider)
The company faces challenges in the dental market, including soft equipment sales and pricing pressures, which could hinder performance. (Markets Insider)
Henry Schein operates in a highly competitive medical product distribution market, contending with larger players like McKesson Corp., which may impact its market share and profitability. (Nasdaq)
Data summarised monthly by Lightyear AI. Last updated on 9 Jul 2025.
Henry Schein Financial Performance
Revenues and expenses
Henry Schein Earnings Performance
Company profitability
Henry Schein News
AllArticlesVideos
Henry Schein to Webcast Second Quarter 2025 Conference Call on Tuesday, August 5, 2025, at 8:00 a.m. ET
Business Wire·3 days ago
IntelePeer Joins Henry Schein One Academic Partner Program
Business Wire·1 week ago
Stanley M. Bergman to Retire as Henry Schein's Chief Executive Officer at the End of 2025
Business Wire·1 week ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Henry Schein stock?
Henry Schein (HSIC) has a market cap of $8.8B as of July 25, 2025.
What is the P/E ratio for Henry Schein stock?
The price to earnings (P/E) ratio for Henry Schein (HSIC) stock is 22.63 as of July 25, 2025.
Does Henry Schein stock pay dividends?
No, Henry Schein (HSIC) stock does not pay dividends to its shareholders as of July 25, 2025.
When is the next Henry Schein dividend payment date?
Henry Schein (HSIC) stock does not pay dividends to its shareholders.
What is the beta indicator for Henry Schein?
Henry Schein (HSIC) has a beta rating of 0.87. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.